Financing
Debt Issuance Proceeds
Elevance Health Debt Issuance Proceeds decreased by 41.6% to $2.99B in Q3 2025 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ3 2025Oct 21, 2025
How to read this metric
An increase indicates successful access to capital markets for expansion or refinancing, while a decrease may suggest a focus on deleveraging or limited market access.
Detailed definition
This metric tracks the total cash proceeds received from the issuance of long-term or short-term debt instruments. It re...
Peer comparison
Large-cap companies frequently issue debt to optimize their cost of capital; peers monitor this to maintain investment-grade credit ratings.
Metric ID:
debt_issuanceHistorical Data
10 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.30B | $0.00 | $1.79B | $2.57B | $0.00 | $2.58B | $0.00 | $5.13B | $2.99B |
| QoQ Change | — | — | -100.0% | — | +44.2% | -100.0% | — | -100.0% | — | -41.6% |
| YoY Change | — | — | — | — | — | -100.0% | — | — | — | — |
Range$0.00 – $5.13B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Debt Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Elevance Health's debt issuance proceeds?
- Elevance Health (ELV) reported debt issuance proceeds of $2.99B in Q3 2025.
- What does debt issuance proceeds mean?
- Cash received from taking on new debt.